Literature DB >> 10853887

Evaluation of core decompression for early osteonecrosis of the femoral head.

S Maniwa1, T Nishikori, S Furukawa, K Kajitani, A Iwata, U Nishikawa, M Ochi.   

Abstract

Twenty-six hips (19 patients) with osteonecrosis of the femoral head with stage I or II of the disease, according to the Ficat and Arlet classification, underwent core decompression. Osteonecrosis was confirmed histologically in all 26 hips. Of 19 patients, 7 had prognostic factors traditionally associated with poor outcome including collagen vascular disease and continued use of steroids. The follow-up period averaged 7 years 10 months (range: 2 years 5 months-13 years 8 months) for 17 patients with 24 hips. Two patients died secondary to systemic illness. Seventeen hips (65.4%) had very good or good results using the Ficat criteria. Eight hips (30.8%) needed further operation [total hip arthroplasty (THA) for 7 hips, osteotomy for 1 hip]. Of the 12 hips in patients who had used steroids, 6 hips (50%) were converted to THA. Four hips in patients with systemic lupus erythematosus (SLE) needed THA (100%). We conclude that core decompression provides an effective treatment for steroid-associated osteonecrosis other than in cases with SLE, as well as providing effective treatment for non-steroid-associated osteonecrosis in the early stages of the disease.

Entities:  

Mesh:

Year:  2000        PMID: 10853887     DOI: 10.1007/s004020050456

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  16 in total

1.  A current review of core decompression in the treatment of osteonecrosis of the femoral head.

Authors:  Todd P Pierce; Julio J Jauregui; Randa K Elmallah; Carlos J Lavernia; Michael A Mont; James Nace
Journal:  Curr Rev Musculoskelet Med       Date:  2015-09

Review 2.  Which factors influence preservation of the osteonecrotic femoral head?

Authors:  Jay R Lieberman; Stephen M Engstrom; R Michael Meneghini; Nelson Fong SooHoo
Journal:  Clin Orthop Relat Res       Date:  2012-02       Impact factor: 4.176

3.  Treatment of osteonecrosis of the femoral head in lymphoma patients by free vascularised fibular grafting.

Authors:  Si Yin; Changqing Zhang; Dongxu Jin; Shengbao Chen; Yuan Sun; Jiageng Sheng
Journal:  Int Orthop       Date:  2010-05-14       Impact factor: 3.075

4.  Treatment of Femoral Head Osteonecrosis (Stages 2B, 3 Ficat) Through Open Direct Core Decompression by Allograft Impaction and Light Bulb Technique.

Authors:  Shahram Shiravani Brojeni; Hamid Hesarikia; Amirhossein Rahimnia; Mohammad Kazem Emami Meybodi; Alireza Rahimnia
Journal:  Arch Bone Jt Surg       Date:  2020-09

5.  Closed bone graft epiphysiodesis for avascular necrosis of the capital femoral epiphysis.

Authors:  George H Thompson; Ethan S Lea; Kenneth Chin; Raymond W Liu; Jochen P Son-Hing; Allison Gilmore
Journal:  Clin Orthop Relat Res       Date:  2013-07       Impact factor: 4.176

6.  SAS weekly rounds: avascular necrosis.

Authors:  Thomas W Hamilton; Susan M Goodman; Mark Figgie
Journal:  HSS J       Date:  2009-03-18

7.  Magnetic resonance imaging criteria of successful core decompression in avascular necrosis of the hip.

Authors:  S Radke; S Kirschner; V Seipel; C Rader; J Eulert
Journal:  Skeletal Radiol       Date:  2004-06-23       Impact factor: 2.199

8.  Three-dimensional-printed titanium alloy porous scaffold combined with trans-cinnamaldehyde for repairing osteonecrosis of the femoral head in a dog model.

Authors:  Runzi Gao; Wenhui Ji; Tianwei Xia; Yanxing Fan; Wei Wei; Le Shi; Jinzhu Liu; Chao Zhang; Lezhen Xue; Jirong Shen
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

Review 9.  Do modern techniques improve core decompression outcomes for hip osteonecrosis?

Authors:  David R Marker; Thorsten M Seyler; Slif D Ulrich; Siddharth Srivastava; Michael A Mont
Journal:  Clin Orthop Relat Res       Date:  2008-04-08       Impact factor: 4.176

Review 10.  Total Hip Arthroplasty in Systemic Lupus Erythematosus: A Systematic Review.

Authors:  John W Kennedy; Wasim Khan
Journal:  Int J Rheumatol       Date:  2015-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.